Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$14,293,608
+$3,203,942 QoQ
Shares Held
11,917
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#1,058
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODSTOCK CORP holds $82,946,085 across 8 Drug Manufacturers - General names. LLY ranks #4 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
92,705 | $23,328,286 | |
| 2 | JNJ |
Johnson & Johnson
|
79,663 | $20,232,012 | |
| 3 | MRK |
Merck & Co., Inc.
|
123,729 | $15,899,176 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
11,917 | $14,293,608 | |
| 5 | AMGN |
Amgen Inc
|
12,301 | $4,454,438 | |
| 6 | PFE |
Pfizer Inc
|
90,767 | $2,185,669 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,671 | $2,112,983 | |
| 8 | NVS |
Novartis AG
|
2,807 | $439,913 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,293,608 | 11,917 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $11,089,666 | 12,057 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $12,837,053 | 11,945 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $9,134,636 | 11,972 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $7,909,890 | 10,147 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $7,264,704 | 8,796 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $6,382,896 | 8,268 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,221,296 | 8,151 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $7,269,296 | 8,029 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $6,389,385 | 8,213 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $4,769,451 | 8,182 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $4,554,862 | 8,480 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,976,950 | 8,480 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $2,911,514 | 8,478 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $3,092,811 | 8,454 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $2,737,481 | 8,466 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,810,824 | 5,585 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,589,639 | 5,551 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $1,528,601 | 5,534 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $1,276,320 | 5,524 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $1,263,507 | 5,505 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $986,783 | 5,282 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $762,819 | 4,518 | Shares | Sole | 2021-01-06 | |
| 2020-09-30 | $384,852 | 2,600 | Shares | Sole | 2020-10-02 | |
| 2020-06-30 | $591,048 | 3,600 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $499,392 | 3,600 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||